For this week's bonus episode of the History of Drugs in Society, I spoke to Andrew Cunningham who heads the drug markets, crime and supply reduction section of the EMCDDA, which stands for European Monitoring Centre for Drugs and Drug Addiction and is the main drug-focused agency across the EU. This interview is focused on a recent report titled “EU Drug Markets Impact of COVID-19“ that was co-authored by Andrew, his colleagues at the EMCDDA, and colleagues at Europol.